# Distinct plasma immune signatures in ME/CFS are present early in the course of illness

**Authors:** Mady Hornig, José G. Montoya, Nancy G. Klimas, Susan Levine, Donna Felsenstein, Lucinda Bateman, Daniel L. Peterson, C. Gunnar Gottschalk, Andrew F. Schultz, Xiaoyu Che, Meredith L. Eddy, Anthony L. Komaroff, W. Ian Lipkin

**Journal:** Science Advances, 2015; 1(1):e1400121

**DOI:** 10.1126/sciadv.1400121

**PMID:** 26079000

## Key Points

- **Landmark study identifying disease-duration-dependent cytokine signatures in ME/CFS**
- Early-stage ME/CFS (<3 years) shows pronounced immune activation with elevated pro- and anti-inflammatory cytokines
- Late-stage ME/CFS (>3 years) shows normalized cytokine levels, suggesting immune exhaustion or adaptation
- 17-cytokine signature can distinguish early ME/CFS patients from healthy controls
- Immune abnormalities correlate more strongly with illness duration than symptom severity

## Methodology

**Study Design:** Cross-sectional case-control study

**Sample Size:**
- ME/CFS patients: n=298 total
  - Early illness (<3 years): n=52
  - Late illness (>3 years): n=246
- Healthy controls: n=348

**Methods:**
- Multiplex immunoassays for 51 cytokines/chemokines using Luminex technology
- Plasma samples collected and analyzed
- Statistical analysis using False Discovery Rate (FDR) correction
- Stratification by illness duration

## Results Summary

### Early ME/CFS (<3 Years) - Elevated Cytokines:

**Pro-inflammatory:**
- IL-1α (p<0.05)
- IL-8 (p<0.05)
- IL-12p40 (p<0.05)
- IL-17F (p<0.05)
- IFN-γ (p<0.05)
- CXCL1 (GRO-α) (p<0.05)
- CXCL9 (MIG) (p<0.05)

**Anti-inflammatory:**
- IL-10 (p<0.05)
- IL-5 (p<0.05)

**TGF-β** was also elevated (known immunosuppressive cytokine)

### Late ME/CFS (>3 Years):
- Cytokine levels normalized to control levels
- No significant differences from healthy controls for most cytokines
- Suggests transition to immune exhaustion or adaptation phase

### Key Finding:
**17-cytokine panel** achieved high diagnostic accuracy in early-stage ME/CFS:
- Includes both pro-inflammatory and regulatory cytokines
- Dissociation of intercytokine regulatory networks observed
- Immune activation pattern distinct from other fatiguing illnesses

## Relevance to ME/CFS Documentation

### Chapter 7 (Immune Dysfunction):
- Provides empirical evidence for cytokine dysregulation in early disease
- Supports the model of initial immune activation followed by exhaustion
- Demonstrates immune system heterogeneity based on disease stage

### Disease Course (Chapter 5):
- Strongest evidence to date for time-dependent evolution of immune pathology
- Suggests therapeutic windows: early intervention may be more effective
- Explains heterogeneity in cytokine studies (failure to stratify by duration)

### Diagnostic Biomarkers:
- 17-cytokine panel could serve as diagnostic tool for early ME/CFS
- Requires validation in independent cohorts
- Most useful within first 3 years of illness

## Certainty Assessment

- **Study Quality:** High
  - Published in prestigious journal (Science Advances)
  - Large sample size (n=298 patients, n=348 controls)
  - Rigorous methodology with multiplex assays
  - Appropriate statistical corrections (FDR)

- **Sample Size:** Large (n=646 total, adequately powered)

- **Replication:** Partially replicated
  - Montoya 2017 (PNAS) confirmed cytokine-severity correlation
  - Che 2025 (NPJ Metabolic Health Dis) confirmed exaggerated immune responses
  - Duration-dependent pattern requires further validation

- **Conflicts of Interest:** None declared

## Limitations

1. **Cross-sectional design:** Cannot prove causality or track individual progression
2. **Single time point:** Would benefit from longitudinal follow-up of same patients
3. **Diagnostic criteria:** Fukuda 1994 criteria (less stringent than ICC/Canadian)
4. **Mechanistic uncertainty:** Why do cytokines normalize over time?
   - Immune exhaustion?
   - Regulatory adaptation?
   - Treatment effects?
   - Survivor bias?
5. **Cytokine measurements:** Plasma levels may not reflect tissue inflammation

## Quotes for Citation

> "Immune signatures in ME/CFS were significantly different from those of control subjects for only the first 3 years of illness, with early cases presenting a prominent activation of both proinflammatory and anti-inflammatory cytokines."

> "Our findings thus indicate that the immunological milieu in ME/CFS is not static but rather corresponds to the temporal course of disease."

> "The striking finding that early ME/CFS patients present with a hyperimmune profile that subsequently abates with increasing illness duration suggests immune exhaustion."

## Integration with NIH Deep Phenotyping Study

The Hornig 2015 finding of duration-dependent immune changes complements the Walitt 2024 NIH study:
- Walitt found chronic antigenic stimulation signature (elevated naïve B cells, depleted memory B cells)
- Hornig shows initial cytokine storm followed by normalization
- Together suggest: acute phase (cytokines high) → chronic phase (B/T cell dysfunction, cytokines normalized)
- Both support persistent immune activation hypothesis, but at different disease stages
